Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Jazz Pharmaceuticals Sees FY24 Adj EPS $19.20-$20.30 Vs $18.51 Est.; Revenue $4.0B-$4.1B Vs $4.047B Est.

Author: Benzinga Newsdesk | July 31, 2024 04:26pm

Posted In: JAZZ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist